Fill out the short form to receive instant access to this webinar.
Register to View the Webinar RecordingThis True Conversations webinar will cover:
- Preview the drugs and therapeutic categories expected to drive the biggest changes in spend, access, and outcomes in 2026, including:
- GLP-1 agents entering new therapeutic areas beyond diabetes and weight loss
- First-in-class treatments for underserved conditions
- High-impact biosimilars creating formulary opportunities
- Gene therapies moving from pipeline to reality
- Understand the Impact: With over 80% of potential 2026 FDA approvals falling into specialty categories, learn how these pipeline trends could affect employer budgets, benefit design strategies, and member health outcomes.
- Plan Ahead: Gain practical strategies to anticipate pipeline changes, adjust formulary positioning, and support informed, proactive decisions before new drug launches create urgency.
- Stay Strategic: Hear how Health Strategists approach emerging therapies to balance innovation, member access, and cost control, turning pipeline uncertainty into your strategic advantage.
Originally aired on November 12, 2025.
